Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
meropenem (merrem) (1 trial)
piperacillin (pipracil) (1 trial)
tazobactam (Zosyn) (1 trial)
COVID-19 convalescent plasma (1 trial)
hydroxychloroquine (plaquenil) (1 trial)
lopinavir (Kaletra) (1 trial)
ritonavir (Norvir) (1 trial)
Communicable Diseases (Phase 3)
Infections (Phase 4)
Trials (2 total)
Trial APIs (7 total)